Innovating Works

filtrando por convocatoria: HORIZON-HLTH-2022-STAYHLTH-02-01

Mostrando 1 al 20 de 22 resultados
PROTO: PROTO - Advanced PeRsOnalized Therapies for Osteoarthritis – TACKLING INFLAMMATION TO IMPROVE PATIEN... CHARITE UNIVERSITAETSMEDIZIN BERLIN tramitó un HORIZON EUROPE: HORIZON-HLTH-2022-STAYHLTH-02 Osteoarthritis (OA) is the most common form of arthritis worldwide. Chronic low-grade inflammation in the articular environment causes carti...
2022-11-17 - 2027-12-31 | Financiado
CARE-IN-HEALTH: CArdiovascularREsolution of INflammation to promote HEALTH INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE tramitó un HORIZON EUROPE: HORIZON-HLTH-2022-STAYHLTH-02 With 1.9 million deaths and an economic burden estimated to €200 billion each year in Europe, cardiovascular diseases (CVD) represent a sign...
2023-01-01 - 2027-12-31 | Financiado
INITIALISE: Inflammation in human early life: targeting impacts on life-course health TURUN YLIOPISTO tramitó un HORIZON EUROPE: HORIZON-HLTH-2022-STAYHLTH-02 The development of the human immune system in early life, including in utero, impacts the risks of several diseases later in life, particula...
2023-01-01 - 2028-12-31 | Financiado
miGut-Health: Personalised blueprint intestinal health UNIVERSITATSKLINIKUM SCHLESWIGHOLSTEIN tramitó un HORIZON EUROPE: HORIZON-HLTH-2022-STAYHLTH-02 The miGut-Health consortium aims to develop a personalized blueprint of intestinal health to predict and prevent inflammatory bowel disease....
2023-01-01 - 2026-12-31 | Financiado
PRAESIIDIUM: PHYSICS INFORMED MACHINE LEARNING-BASED PREDICTION AND REVERSION OF IMPAIRED FASTING GLUCOSE MANAGEM... SPINDOX LABS SRL tramitó un HORIZON EUROPE: HORIZON-HLTH-2022-STAYHLTH-02 The incidence of undiagnosed diabetes accounts for 36% European adults, while 541M adults worldwide have Impaired Glucose Tolerance (IGT), a...
2023-01-01 - 2025-12-31 | Financiado
GlycanTrigger: GLYCANS AS MASTER TRIGGERS OF HEALTH TO INTESTINAL INFLAMMATION TRANSITION I3S INSTITUTO DE INVESTIGACAO E INOVACAO EM SAUDE DA UNIVERSIDADE DO PORTO tramitó un HORIZON EUROPE: HORIZON-HLTH-2022-STAYHLTH-02 Chronic inflammation underlies several diseases. In Crohn´s disease (CD), there is mounting evidence of a preclinical phase characterized by...
2023-01-01 - 2028-12-31 | Financiado
INTERCEPT-T2D: Early Interception of Inflammatory-mediated Type 2 Diabetes INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE tramitó un HORIZON EUROPE: HORIZON-HLTH-2022-STAYHLTH-02 The overall concept of INTERCEPT-T2D is to establish whether an inflammatory-mediated profile contributes to the onset of Type 2 Diabetes (T...
2023-01-01 - 2027-12-31 | Financiado
PREVALUNG EU: Biomarkers affecting the transition from cardiovascular disease to lung cancer: towards stratified i... INSTITUT GUSTAVE ROUSSY tramitó un HORIZON EUROPE: HORIZON-HLTH-2022-STAYHLTH-02 Cardiovascular disease (CVD) and lung cancer (LC) are leading causes of deaths and intertwined chronic inflammatory processes associated wit...
2022-12-01 - 2027-11-30 | Financiado
iPROLEPSIS: iPROLEPSIS: PSORIATIC ARTHRITIS INFLAMMATION EXPLAINED THROUGH MULTI-SOURCE DATA ANALYSIS GUIDING A... ARISTOTELIO PANEPISTIMIO THESSALONIKIS tramitó un HORIZON EUROPE: HORIZON-HLTH-2022-STAYHLTH-02 Psoriatic Arthritis (PsA) is a chronic, progressive, inflammatory disease affecting 1-2% of the general population, while manifesting in up...
2023-01-01 - 2026-12-31 | Financiado
ENDOTARGET: Systemic Endotoxemia as the driver of chronic inflammation - Biomarkers and novel therapeutic target... HUSYHTYMA tramitó un HORIZON EUROPE: HORIZON-HLTH-2022-STAYHLTH-02 Rheumatic diseases (RDs) affect more than 40% of Europe's population and cause significant disability, pain, reduced lifespan and a very hig...
2023-01-01 - 2026-12-31 | Financiado
IMMEDIATE: Imminent Disease Prediction and Prevention at the Environment Host Interface CHARITE UNIVERSITAETSMEDIZIN BERLIN tramitó un HORIZON EUROPE: HORIZON-HLTH-2022-STAYHLTH-02 IMMEDIATE aims to investigate and explore the diet-microbiome-immunometabolism-axis as a sensor for health-to-disease transition and evaluat...
2023-01-01 - 2026-12-31 | Financiado
ENDOTARGET: Systemic Endotoxemia as the driver of chronic inflammation - Biomarkers and novel therapeutic target... HUSYHTYMA tramitó un HORIZON EUROPE: HORIZON-HLTH-2022-STAYHLTH-02 Rheumatic diseases (RDs) affect more than 40% of Europe's population and cause significant disability, pain, reduced lifespan and a very hig...
2022-11-15 - 2026-12-31 | Financiado
PREVALUNG EU: Biomarkers affecting the transition from cardiovascular disease to lung cancer: towards stratified i... INSTITUT GUSTAVE ROUSSY tramitó un HORIZON EUROPE: HORIZON-HLTH-2022-STAYHLTH-02 Cardiovascular disease (CVD) and lung cancer (LC) are leading causes of deaths and intertwined chronic inflammatory processes associated wit...
2022-11-24 - 2027-11-30 | Financiado
halt-RONIN: Discovering chronic inflammation biomarkers that define key stages in the Healthy to NASH non alcoh... Universidad Complutense de Madrid tramitó un HORIZON EUROPE: HORIZON-HLTH-2022-STAYHLTH-02 Non-alcoholic fatty liver disease (NAFLD) is a multifactorial chronic inflammatory disease that is prevalent in 1 of 4 individuals with a si...
2022-11-22 - 2026-11-30 | Financiado
CARE-IN-HEALTH: CArdiovascularREsolution of INflammation to promote HEALTH With 1.9 million deaths and an economic burden estimated to €200 billion each year in Europe, cardiovascular diseases (CVD) represent a sign...
2022-11-15 - 2027-12-31 | Financiado
iPROLEPSIS: iPROLEPSIS PSORIATIC ARTHRITIS INFLAMMATION EXPLAINED THROUGH MULTI SOURCE DATA ANALYSIS GUIDING A... Psoriatic Arthritis (PsA) is a chronic, progressive, inflammatory disease affecting 1-2% of the general population, while manifesting in up...
2022-12-01 - 2026-12-31 | Financiado
INTERCEPT-T2D: Early Interception of Inflammatory mediated Type 2 Diabetes The overall concept of INTERCEPT-T2D is to establish whether an inflammatory-mediated profile contributes to the onset of Type 2 Diabetes (T...
2022-11-23 - 2027-12-31 | Financiado
miGut-Health: Personalised blueprint intestinal health The miGut-Health consortium aims to develop a personalized blueprint of intestinal health to predict and prevent inflammatory bowel disease....
2022-11-11 - 2026-12-31 | Financiado
GlycanTrigger: GLYCANS AS MASTER TRIGGERS OF HEALTH TO INTESTINAL INFLAMMATION TRANSITION Chronic inflammation underlies several diseases. In Crohn´s disease (CD), there is mounting evidence of a preclinical phase characterized by...
2022-12-05 - 2028-12-31 | Financiado
INITIALISE: Inflammation in human early life targeting impacts on life course health The development of the human immune system in early life, including in utero, impacts the risks of several diseases later in life, particula...
2022-11-24 - 2028-12-31 | Financiado